CompletedNCT00206960
Brain activity and cognition before and after treatment for first-episode schizophrenia
About this title
Read the official source — NCT00206960This study assessed thinking abilities.
Medication studyAges 18–45Denmark
Understand this study
What did researchers investigate?
This study assessed thinking abilities.
Who was this study for?
Listed age limits: 18 years to 45 years.
- Listed locations
- Copenhagen and 5 more locationsSee all locations and recruitment
Study information
Study start dateJanuary 1998
- Recruitment status
- Completed
- Enrollment listed in the registry
- 56
- Sponsor
- Birte Glenthoj
- Sponsor type
- Unknown or unclear
- Study type
- Drug
- Intervention type
- Drug
- Locations
- Denmark
- Age range
- From 18 Years to 45 Years
- Official registry ID
- NCT00206960
- Official title
Show the full official title
Effects of Classical and Atypical Antipsychotics on Dopamine Receptor Binding of 123I-epidepride, Cognition, Startle Response and Extrapyramidal Side-effects in Drug-naive First-episode Schizophrenic Patients
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Copenhagen · Copenhagen NV · Glostrup Municipality
1 more locations
- Hvidovre
Interested in joining this study?
Questions about this study
What did researchers investigate?
This study assessed thinking abilities.
Who is behind this study?
The study sponsor is Birte Glenthoj.
Did this study involve medication?
Yes. The study involved medication, including zuclopenthixol and risperidone.
Who was this study for?
Listed age limits: 18 years to 45 years.
